CU20100008A7 - Estratrienos 8-beta sustituidos como estrógenos de acción selectiva - Google Patents
Estratrienos 8-beta sustituidos como estrógenos de acción selectivaInfo
- Publication number
- CU20100008A7 CU20100008A7 CUP2010000008A CU20100008A CU20100008A7 CU 20100008 A7 CU20100008 A7 CU 20100008A7 CU P2010000008 A CUP2010000008 A CU P2010000008A CU 20100008 A CU20100008 A CU 20100008A CU 20100008 A7 CU20100008 A7 CU 20100008A7
- Authority
- CU
- Cuba
- Prior art keywords
- stratriens
- strateges
- selective action
- preparations
- beta
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
- C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
Abstract
Derivados de estra-1,3,5(10)-trieno 8beta-sustituidos de fórmula general I ESPACIO PARA LA FÓRMULA su uso como ingredientes farmacéuticos activos que tienen una mayor afinidad in vitro por preparaciones de receptores de estrógeno de próstata de rata que por preparaciones de receptores de estrógeno de útero de rata, y que presentan una acción preferencial in vivo en el ovario en comparación con el útero, con su producción, su uso terapéutico, y con formas de administración que contienen los nuevos compuestos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07075600A EP2014672A1 (en) | 2007-07-12 | 2007-07-12 | 8-beta-substituted estratrienes as selectively active estrogens |
PCT/EP2008/059115 WO2009007454A2 (en) | 2007-07-12 | 2008-07-11 | 8-beta-substituted estratrienes as selectively active estrogens |
Publications (2)
Publication Number | Publication Date |
---|---|
CU20100008A7 true CU20100008A7 (es) | 2011-05-27 |
CU23885B1 CU23885B1 (es) | 2013-04-19 |
Family
ID=38657613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CU20100008A CU23885B1 (es) | 2007-07-12 | 2010-01-12 | Estratrienos 8-beta sustituidos como estrógenos de acción selectiva |
Country Status (34)
Country | Link |
---|---|
US (1) | US20090029957A1 (es) |
EP (2) | EP2014672A1 (es) |
JP (1) | JP2010533152A (es) |
KR (1) | KR20100037593A (es) |
CN (1) | CN101687902B (es) |
AR (1) | AR067507A1 (es) |
AU (1) | AU2008274198A1 (es) |
BR (1) | BRPI0814207A2 (es) |
CA (1) | CA2692727A1 (es) |
CL (1) | CL2008002027A1 (es) |
CO (1) | CO6270230A2 (es) |
CR (1) | CR11211A (es) |
CU (1) | CU23885B1 (es) |
CY (1) | CY1113351T1 (es) |
DK (1) | DK2176282T3 (es) |
DO (1) | DOP2010000017A (es) |
EA (1) | EA017124B1 (es) |
EC (1) | ECSP109872A (es) |
ES (1) | ES2393942T3 (es) |
HN (1) | HN2010000081A (es) |
HR (1) | HRP20120952T1 (es) |
MA (1) | MA31565B1 (es) |
NZ (1) | NZ582490A (es) |
PA (1) | PA8789401A1 (es) |
PE (1) | PE20090825A1 (es) |
PL (1) | PL2176282T3 (es) |
PT (1) | PT2176282E (es) |
RS (1) | RS52541B (es) |
SI (1) | SI2176282T1 (es) |
TN (1) | TN2010000007A1 (es) |
TW (1) | TW200911824A (es) |
UA (1) | UA99918C2 (es) |
UY (1) | UY31220A1 (es) |
WO (1) | WO2009007454A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2830984C (en) * | 2011-03-25 | 2020-02-11 | Universite Laval | Inhibitors of 17.beta.-hsd1, 17.beta.-hsd3 and 17.beta.-hsd10. |
US10744439B2 (en) * | 2016-06-24 | 2020-08-18 | K&N Engineering, Inc. | Compound air filter and method of removing airborne molecular contaminants and volatile organic compounds therefrom |
USD905747S1 (en) | 2018-04-09 | 2020-12-22 | Mitsubishi Electric Corporation | Display screen with animated graphical user interface |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10019167A1 (de) * | 2000-04-12 | 2001-10-18 | Schering Ag | Substituierte Estratriene als selektiv wirksame Estrogene |
AU2001258341B2 (en) * | 2000-04-12 | 2007-03-15 | Schering Aktiengesellschaft | 8beta-hydrocarbyl-substituted estratrienes for use as selective estrogens |
-
2007
- 2007-07-12 EP EP07075600A patent/EP2014672A1/en not_active Ceased
-
2008
- 2008-07-11 SI SI200830826T patent/SI2176282T1/sl unknown
- 2008-07-11 TW TW097126522A patent/TW200911824A/zh unknown
- 2008-07-11 JP JP2010515526A patent/JP2010533152A/ja not_active Ceased
- 2008-07-11 NZ NZ582490A patent/NZ582490A/en not_active IP Right Cessation
- 2008-07-11 CN CN200880024423XA patent/CN101687902B/zh not_active Expired - Fee Related
- 2008-07-11 PL PL08775031T patent/PL2176282T3/pl unknown
- 2008-07-11 BR BRPI0814207-6A2A patent/BRPI0814207A2/pt not_active IP Right Cessation
- 2008-07-11 CA CA 2692727 patent/CA2692727A1/en not_active Abandoned
- 2008-07-11 US US12/171,424 patent/US20090029957A1/en not_active Abandoned
- 2008-07-11 UY UY31220A patent/UY31220A1/es not_active Application Discontinuation
- 2008-07-11 WO PCT/EP2008/059115 patent/WO2009007454A2/en active Application Filing
- 2008-07-11 PA PA20088789401A patent/PA8789401A1/es unknown
- 2008-07-11 PE PE2008001165A patent/PE20090825A1/es not_active Application Discontinuation
- 2008-07-11 RS RS20120516A patent/RS52541B/en unknown
- 2008-07-11 AR ARP080102978A patent/AR067507A1/es unknown
- 2008-07-11 CL CL2008002027A patent/CL2008002027A1/es unknown
- 2008-07-11 AU AU2008274198A patent/AU2008274198A1/en not_active Abandoned
- 2008-07-11 KR KR1020107000527A patent/KR20100037593A/ko not_active Application Discontinuation
- 2008-07-11 ES ES08775031T patent/ES2393942T3/es active Active
- 2008-07-11 PT PT08775031T patent/PT2176282E/pt unknown
- 2008-07-11 UA UAA201001369A patent/UA99918C2/ru unknown
- 2008-07-11 EP EP08775031A patent/EP2176282B1/en active Active
- 2008-07-11 EA EA201000097A patent/EA017124B1/ru not_active IP Right Cessation
- 2008-07-11 DK DK08775031.1T patent/DK2176282T3/da active
-
2010
- 2010-01-07 MA MA32490A patent/MA31565B1/fr unknown
- 2010-01-07 TN TNP2010000007A patent/TN2010000007A1/fr unknown
- 2010-01-12 DO DO2010000017A patent/DOP2010000017A/es unknown
- 2010-01-12 CU CU20100008A patent/CU23885B1/es not_active IP Right Cessation
- 2010-01-12 HN HN2010000081A patent/HN2010000081A/es unknown
- 2010-01-12 CO CO10002339A patent/CO6270230A2/es active IP Right Grant
- 2010-01-12 EC EC2010009872A patent/ECSP109872A/es unknown
- 2010-01-12 CR CR11211A patent/CR11211A/es not_active Application Discontinuation
-
2012
- 2012-11-14 CY CY20121101099T patent/CY1113351T1/el unknown
- 2012-11-21 HR HRP20120952AT patent/HRP20120952T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016001809A1 (es) | Derivados 11-hidroxilo de acidos biliares y conjugados de aminoacidos de los mismos como moduladores del receptor de farnesoid x (divisional sol. n° 3344-15). | |
GT201000008A (es) | Agentes citotoxicos que comprenden nuevos derivados de tomaimicina y su uso terapeutico | |
NI201500106A (es) | Derivados de benzotiofeno y composiciones de los mismos como degradantes selectivos de los receptores de estrógeno. | |
UY31080A1 (es) | Derivados de pirazol sustituidos con heteroarilo utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis | |
UY33470A (es) | Derivados de 6,7-dihidro-5h-benzo[7]anulenos, métodos para su preparación, preparaciones farmacéuticas que los contienen y su uso para la preparación de medicamentos | |
CR11802A (es) | Derivados de indazoles sustituidos con fenilo o piridinilo | |
UY31079A1 (es) | Derivados de fenilaminobenceno sustituidos de utilidad para el tratamiento de trastornos y enfermedades hiperproliferativos asociados con actividad quinasa extracelular mediada por mitógenos | |
UY29701A1 (es) | Formulaciones líquidas para la administración controlada de derivados de bencisoxazol | |
CL2011003172A1 (es) | Composicion farmaceutica que comprende a) un excepiente, b) al menos un precursor de esteroides sexuales, c) al menos un modulador selectivo del receptor de estrogenos o una antiestrogeno y no contiene una progestina y/o un estrogeno; kit farmaceutico; y uso para reducir o eliminar sofocos, sintomas vasomotores y sudores nocturnos. | |
UY31922A (es) | Compuestos | |
PA8623101A1 (es) | Compuestos farmaceuticamente activos | |
PE20070188A1 (es) | Formulaciones de estrogenos conjugados y bazedoxifeno | |
HN2011002578A (es) | Nuevos derivados de compuestos de [3,2-c]pirazol esteroidal con actividad clucocorticoide. | |
ECSP055530A (es) | Estratrienos 9-alfa-sustituidos como estrógenos de eficacia selectiva | |
PE20151783A1 (es) | Dispersion solida de un modulador selectivo de los receptores de progesterona | |
UY28911A1 (es) | Profármacos de esteroides con acción androgénica | |
CU20100008A7 (es) | Estratrienos 8-beta sustituidos como estrógenos de acción selectiva | |
SV2009003168A (es) | Derivados de oxazolidona como moduladores pr | |
UY32005A (es) | Derivados de estratrieno que comprenden bioisósteros heterocíclicos para el anillo fenólico a | |
UY29625A1 (es) | Uso de moduladores no esteroides de receptores de progesterona | |
CL2008002289A1 (es) | Compuestos derivados de n-heteroaril-carboxamidas triciclicas; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar dolor, inflamacion, trastornos metabolicos, trastornos urologicos, entre otros. | |
UY31428A1 (es) | Derivados 1,2,4-triazol tiofeno fusionados como moduladores de mglur5 | |
GT200600271A (es) | Moduladores no esterides de receptores de progesterona | |
CL2007002788A1 (es) | Un compuesto derivado de (cis)-8-fluorodibenzo[b,f]pirido[1,2-d]oxazepin-1-amina, modulador de los receptores de progesterona; composicion farmaceutica; y uso como anticonceptivo, para la terapia de reemplazo hormonal o para el tratamiento de un tras | |
UY33393A (es) | Una composición farmacéutica de liberación controlada de losartan |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant of patent | ||
FD | Lapse (for not paying fees) |